Skip to main content
v2026.11,986 entries · CC-BY 4.0
LAC HealthSponsored

Shop heel protector supplies

  • FDA registered
  • ISO 13485
  • BBB Accredited A+

Shop at LAC Health

Heel Protector: What It Is, FDA Class and What the Guideline Says

What a heel protector is, how FDA classifies it (Class I, 510(k)-exempt) and how strongly the 2025 pressure injury guideline supports heel offloading.

Written and maintained by CASRAI Editorial Board

Published · Last updated

On this page

General product and regulatory information only, not medical advice. Decisions about an individual patient belong to that patient’s care team.

Short answer

A heel protector is a device meant to reduce pressure on the skin over the heel bone. In the United States, FDA lists it under “Protector, skin pressure” (product code FMP): a Class I device that is exempt from 510(k) premarket notification. The 2025 international pressure injury guideline gives only a conditional recommendation for heel offloading devices, based on very low certainty evidence.

Definition and scope

The regulation, 21 CFR 880.6450, defines a skin pressure protector as “a device intended for medical purposes that is used to reduce pressure on the skin over a bony prominence to reduce the likelihood of the patient’s developing decubitus ulcers (bedsores).” It is Class I (general controls) and exempt from 510(k), subject to the limits in 21 CFR 880.9. FDA’s product classification database (checked 2026-10-30) lists the same entry under the General Hospital panel with product code FMP.

The definition names a bony prominence, not a body site. Heel protectors, boots and similar heel-offloading products are one use of that wording; elbow protectors, which people search for alongside heel protectors, are another general kind of skin protector. The heel guideline does not rate elbow protectors, so this page makes no effectiveness statement about them.

What the 2025 guideline says about heel offloading devices

The guideline explains why the heel gets attention: the heel is one of the most common sites for pressure injuries, and the back of the heel is covered by only a small volume of tissue. Its heel recommendation H2 (International Guideline, 4th edition, NPIAP/EPUAP/PPPIA, online 16 September 2025, section on heels, checked 2026-10-30) is graded as a conditional recommendation with very low certainty of evidence.

The evidence behind H2 is thin. In the guideline’s analysis, two randomized trials in critical care settings compared a heel offloading device with standard pillows or a regular foam bootee: heel pressure injuries occurred in 0.4% versus 8.4% of heels, and the guideline describes very little confidence that this estimate reflects a true effect.

Marketing language versus guideline language

Product pages tend to describe features. The guideline instead describes the strength of evidence and the known drawbacks of devices.

Question What the guideline says
How strong is the evidence for a device? Conditional recommendation, very low certainty of evidence (H2).
Does fit matter? “A heel offloading device that is not correctly fitted and used could cause device-related PIs” (expert panel opinion).
Any downsides? Expert opinion: devices may reduce movement in bed and may raise fall risk in people who walk. One evaluated boot was rated warm or sweaty by 70% of those asked.

The guideline uses “heel offloading device” for products such as a boot, pillow or cushion that keep the heel free of the support surface. A product sold as a “heel protector” is therefore one product type within that family.

Heel protectors versus preventive heel dressings

These are different product categories. The guideline separately analyses preventive heel dressings (soft silicone multilayered foam), which are not offloading devices. See pressure injury prevention programmes for the program context. To judge which patients are at risk in the first place, see the Braden Scale, which scores six subscales of pressure injury risk.

Elbow protectors

Covered by the same general regulation wording on bony prominences, as noted above. The heel guideline does not address them.

Where it matters for labs, clinics and supply decisions

  • Regulatory status is not an evidence rating. Class I and 510(k)-exempt describes how FDA regulates the product category; it says nothing about how well any individual product works. Class I devices remain subject to general controls, including the complaint-handling record requirement noted in the regulation. See also medical device reporting (MDR) and the Medical Device Amendments of 1976.
  • Policy first. The guideline places device selection under local policies and the collaborative care team, so a facility’s own policy is the governing document, not a product description.
  • Related reading. Nursing home supply checklist, and for adjacent lower-limb devices how a walking boot works.

Common misunderstandings

  • “Class I, exempt, so there is no evidence needed.” Exemption concerns premarket notification, not clinical effectiveness.
  • “Any boot offloads the heel.” The guideline stresses correct fit and use; its expert panel notes a poorly fitted device can cause a device-related pressure injury.
  • “A device is proven better than alternatives.” The guideline’s own recommendation is conditional with very low certainty.
  • “Elbow protectors are guideline-backed.” The heel guideline section does not cover them.

FAQ

What is a heel protector?

A device meant to reduce pressure on the skin over the heel bone. FDA classifies skin pressure protectors under 21 CFR 880.6450 as Class I.

Does FDA clear heel protectors?

Under 21 CFR 880.6450 they are exempt from 510(k) premarket notification, subject to the limits in 21 CFR 880.9, so there is generally no 510(k) clearance to look up.

What is an elbow protector?

A protector worn over the elbow. The regulatory wording on devices reducing pressure over a bony prominence is general, and the heel guideline does not rate elbow protectors.

How strong is the evidence for heel offloading devices?

The 2025 guideline grades its heel offloading device recommendation as conditional, with very low certainty of evidence.

Sources

All sources checked 2026-10-30.

Follow CASRAI

Research-administration guidance, standards updates and independent tool reviews.

Ask CASRAI · free to try

Ask about Heel Protector: What It Is, FDA Class and What the Guideline Says

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →